Delhi HC seeks Centre reply on PIL against Covaxin trial on 2-18 age group Ruchika Sharma20 May 2021 10:00 AM ISTKumar, in his plea, has raised an apprehension that the children who would be part of the trial could suffer adverse health or mental effects due to...
2 CDSCO officials arrested by CBI in bribery case Medical Dialogues Team17 May 2021 3:15 PM ISTAhmedabad: In a case of bribery to the tune of Rs 3.50 lakh, the Central Bureau of Investigation has arrested a medical device officer of the Central...
Torrent Pharma, Eli Lilly ink pact to boost Baricitinib production in India Ruchika Sharma14 May 2021 3:23 PM ISTAhmedabad: Following in the footsteps of Sun Pharma, Cipla, and Lupin in signing a voluntary licencing agreement with Eli Lilly to accelerate the...
Dr Reddys, Eli Lilly collaborate for manufacturing, commercializing Baricitinib in India Ruchika Sharma13 May 2021 9:15 AM ISTHyderabad: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced that the company has entered into a royalty-free, non-exclusive...
Bharat Biotech gets CDSCO panel nod to conduct Covaxin trials on 2-18 years old Ruchika Sharma12 May 2021 12:37 PM ISTNew Delhi: Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged...
DTAB rejects proposal to mandate printing drug labels in Hindi, regional languages Medical Dialogues Team10 May 2021 3:46 PM ISTNew Delhi: Citing the proposal impractical, the Drugs Technical Advisory Board (DTAB) has declined to permit drug labels to be printed in Hindi or...
Eli Lilly ink licensing pact with Sun Pharma, Cipla, Lupin to expedite COVID drug Baricitinib Ruchika Sharma10 May 2021 1:55 PM ISTNew Delhi: Drug firm Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with Indian drug firms -- Sun Pharma, Cipla...
Natco Pharma launches Baricitinib in India without patent waiver approval Medical Dialogues Team7 May 2021 3:26 PM ISTNew Delhi: Casting caution to the wind, Natco Pharma has already started distributing its generic version of the rheumatoid arthritis drug Baricitinib...
Roche India gets CDSCO nod to COVID antibody cocktail of Casirivimab, Imdevimab Ruchika Sharma6 May 2021 2:00 PM ISTThe drug will be available through leading hospitals and COVID treatment centres, Roche India said.
Combating COVID: Eli Lilly accelerating baricitinib availability in India Ruchika Sharma6 May 2021 12:00 PM ISTIndianapolis: Eli Lilly and Company has recently announced new initiatives to help COVID-19 patients in India as part of its commitment to...
Delhi HC asks CDSCO, Cipla to reply on PIL seeking to allow all Remdesivir makers to sell in domestic market Ruchika Sharma4 May 2021 3:24 PM ISTThe petition has also said that huge stocks of the medicine are lying at the ports for being exported and the same can be sold in the domestic market.
Natco Pharma gets CDSCO emergency use nod for Baricitinib for treating COVID Ruchika Sharma3 May 2021 1:31 PM ISTHyderabad: Pharma major, Natco Pharma Limited, announced that the company has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and...
